OCUGEN, INC. Long-Lived Assets
OCUGEN, INC. (OCGN) had Long-Lived Assets of $3.86 million as of 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Notes
us-gaap:NoncurrentAssets · last filed 2017-03-16
- 2016-12-31: Long-Lived Assets $3.86M.
- 2016-09-30: Long-Lived Assets $4.26M.
- 2016-06-30: Long-Lived Assets $4.67M.
- 2016-03-31: Long-Lived Assets $4.82M.
| Period end | Long-Lived Assets |
|---|---|
| 2016-12-31 | $3.86M 10-K · filed 2017-03-16 |
| 2016-09-30 | $4.26M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $4.67M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $4.82M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $5.21M 10-K · filed 2017-03-16 |
| 2015-09-30 | $5.51M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $5.43M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $5.42M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $4.88M 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |